Coya Therapeutics (COYA) is a clinical-stage company focused on developing multi-modality Treg therapies. CEO Howard Berman joins Nicole Petallides to give an overview of the company. He talks about how COYA’s leading candidate is Coya 302 and how the Alzheimer’s Drug Discovery Foundation invested $5M in COYA. Tune in to find out more about the stock market today.
Trading 360
23 May 2024
SHARE